podcast about semaglutide Less of You Podcast: Life on & Tirzepatide Morning Brief Podcast: Semaglutide: Decoding
Description
Many contain additives and preservatives that may affect metabolism or gut health
People who are overweight or obese are at a higher risk of developing type 2 diabetes
Semaglutide also slows down gastric emptying, which makes us feel fuller for longer
Gibbons C, Caudwell P, Finlayson G, Webb DL, Hellstrom PM, Naslund E et al
In June 2021, the FDA approved Semaglutide (Wegovy), a GLP-1 receptor agonist developed by Novo Nordisk, for use as a weight loss drug
Versus semaglutide alone Semaglutide alone already has positive phase 2 and phase 3 MASH histology data
